A detailed history of Optiver Holding B.V. transactions in Novavax Inc stock. As of the latest transaction made, Optiver Holding B.V. holds 453 shares of NVAX stock, worth $3,710. This represents 0.0% of its overall portfolio holdings.

Number of Shares
453
Previous 7,313 93.81%
Holding current value
$3,710
Previous $92,000 96.74%
% of portfolio
0.0%
Previous 0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 14, 2025

SELL
$7.22 - $14.68 $49,529 - $100,704
-6,860 Reduced 93.81%
453 $3,000
Q3 2024

Nov 14, 2024

BUY
$10.71 - $17.11 $78,322 - $125,125
7,313 New
7,313 $92,000

Others Institutions Holding NVAX

About NOVAVAX INC


  • Ticker NVAX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 78,215,104
  • Market Cap $641M
  • Description
  • Novavax, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of vaccines to prevent serious infectious diseases and address health needs. The company's vaccine candidates include NVX-CoV2373, a coronavirus vaccine candidate that is in two Phase III trials, one Phase IIb trial, and one Phase I/II trial; Nan...
More about NVAX
Track This Portfolio

Track Optiver Holding B.V. Portfolio

Follow Optiver Holding B.V. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Optiver Holding B.V., based on Form 13F filings with the SEC.

News

Stay updated on Optiver Holding B.V. with notifications on news.